Rheumatologische Schwerpunktpraxis Dr. Jochen Walter
- Address
- Hollesenstr. 27a, 24768 Rendsburg, Germany
Rheumatologische Schwerpunktpraxis Dr. Jochen Walter
Rheumatologische Schwerpunktpraxis Dr. Jochen Walter is a specialized rheumatology practice dedicated to advancing the understanding and treatment of inflammatory rheumatic conditions. The center focuses on clinical research that evaluates novel therapeutic approaches and monitors long-term treatment outcomes for patients with complex rheumatologic disorders.
- Long-term safety and tolerability studies of biologic therapies
- Polymyalgia rheumatica treatment research
- Subcutaneous immunomodulatory interventions
The practice has established expertise in polymyalgia rheumatica (PMR), participating in multi-center extension studies that assess the prolonged safety profile of advanced treatments such as secukinumab. Through open-label extension trials, the center contributes valuable data on adverse event monitoring and the sustained efficacy of subcutaneous biologic agents, helping to establish comprehensive safety profiles that inform clinical decision-making for patients requiring long-term immunomodulatory therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Rheumatologische Schwerpunktpraxis Dr. Jochen Walter
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis | Acelyrin Inc. | Phase IV | Not Recruiting | Apr 2023 | Oct 2024 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Secukinumab | 3 | Unknown | 2022-09-21 | 2024-11-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.